FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: SEGRO PLC | (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A | (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree SEGRO PLC | (d) Is the discloser the offeror or the offeree? OFFEREE | (e) Date position held: The latest practicable date prior to the disclosure 6 JULY 2026 | (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" YES - PROLOGIS, INC. |
2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary shares of 10 pence each | Interests Short positions | Number % Number % | (1) Relevant securities owned and/or controlled: NIL - NIL - | (2) Cash-settled derivatives: NIL - NIL - | (3) Stock-settled derivatives (including options) and agreements to purchase/sell: NIL - NIL - | TOTAL: NIL - NIL - |
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities
Class of relevant security in relation to which subscription right exists: NONE | Details, including nature of the rights concerned and relevant percentages: NONE |
3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE
Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:
(a) Interests held by directors of SEGRO plc and their close relatives and related trusts
Name
No. of ordinary shares
Percentage of total issued share capital*
Andrew Harrison
564,755
0.04%
Carol Ann Fairweather
20,000
0.00%
David John Rivers Sleath
1,277,499
0.09%
Dr. Linda Yi-Chuang Yueh
4,716[1]
0.00%
Marcus Sperber
11,137
0.00%
Mary Elizabeth Barnard
12,5072
0.00%
Simon William David Fraser
31,440
0.00%
Susan Vivien Clayton
8,0133
0.00%
Susanne Dorothee Schroeter
1,941
0.00%
* Figures are rounded down to two decimal places and are calculated on the basis of SEGRO plc having 1,354,073,367 ordinary shares of 10 pence each in issue (as set out in SEGRO plc's announcement dated 1 July 2026).
[1] 1,559 ordinary shares held by a close relative of Dr. Linda Yi-Chuang Yueh.
2 Held by a close relative of Mary Elizabeth Barnard.
3 1,013 ordinary shares held by a close relative of Susan Vivien Clayton.
(b) Interests held as options or awards under the share plans of SEGRO plc by the directors of SEGRO plc and their close relatives and related trusts
Name
Share plan under which option or award was granted1
No. of ordinary shares in SEGRO plc under option or subject to award1
Date of grant
Exercise price (pence)
Vesting date(s)2
Expiry date
David John Rivers Sleath
LTIP
264,001
22 March 2024
Nil
22 March 2027
-
335,378
19 February 2025
Nil
19 February 2028
-
304,181
25 February 2026
Nil
25 February 2029
-
Sharesave
3,035
15 April 2026
599.52
1 June 2029
1 December 2029
Susanne Dorothee Schroeter
LTIP
128,385
2 December 2025
Nil
19 February 2028
-
105,5143
2 December 2025
Nil
31 March 2027; 31 March 2028
-
169,585
25 February 2026
Nil
25 February 2029
-
Sharesave
3,035
15 April 2026
599.52
1 June 2029
1 December 2029
[1] LTIP awards are structured as conditional awards over ordinary shares. Sharesave is an HMRC approved option scheme.
2 LTIP awards are subject to a three-year performance period followed by a two-year post-vesting holding period.
3 Granted as a recruitment LTIP award on Susanne Dorothee Schroeter's appointment as an executive director of
SEGRO plc, vesting in two equal tranches (50 per cent on 31 March 2027 and 50 per cent on 31 March 2028,
subject to continued employment) and not subject to performance conditions or a post-vesting holding period.
(c) Interests of connected advisers
Name
Calvert Research and Management1
No. of ordinary shares
103,474
Percentage of total issued share capital
0.008
[1] Calvert Research and Management is a group company of Morgan Stanley.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None.
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
None.
(c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO | Supplemental Form 8 (SBL) NO |
| Date of disclosure: 6 July 2026 | Contact name: Stephanie Murton | Telephone number: +44 207 451 9082 |
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END FEEUNVKRNKUBRRR